Gabapentin Capsules 400 mg Recalled for Cross Contamination
Sun Pharmaceutical Industries Inc. is recalling Gabapentin Capsules 400 mg due to cross contamination. The recall affects 852 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as Class III, which by definition is unlikely to cause adverse health consequences. The source text does not report any illnesses or injuries, and no specific contaminant or health hazard is detailed.
Plain-English summary
Sun Pharmaceutical Industries Inc. is voluntarily recalling Gabapentin Capsules, USP 400 mg, Rx Only, due to cross contamination. The affected product was packaged in 500-count bottles (NDC 62756-139-05, Lot HAD1712B, Exp. 03/2025) and 1000-count bottles (NDC 62756-139-04, Lot HAD1712C, Exp. 03/2025). A total of 852 bottles were distributed nationwide in the USA.
The product is manufactured by Sun Pharmaceutical Industries Ltd. in Halol-Baroda Highway, Halol-389 350, Gujarat, India, and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ 08512. The recall was initiated on March 4, 2025, and classified as Class III by the FDA on April 4, 2025.
Patients currently taking the recalled Gabapentin Capsules should consult their healthcare provider or pharmacist. Do not stop taking the medication without medical guidance. Contact Sun Pharmaceutical Industries Inc. with questions about this recall.
The recalled product
- Product
- GABAPENTIN (GABAPENTIN)
- Brand
- GABAPENTIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Prescription Oral
- Hazard
- cross-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # a) HAD1712B
- Exp. date 03/2025 b) HAD1712C
- exp. date 03/2025
UPCs (5)
- 0362756204010
- 0362756202016
- 0362756138025
- 0362756137028
- 0362756139022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GABAPENTIN
- ModerateGabapentin Capsules 100 mg recalled for defective blister packaging
FDA (Drugs) · 2025-07-09
- LowGabapentin Capsules Recalled for Cross Contamination
FDA (Drugs) · 2025-04-16
- ModerateGabapentin 600mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- HighGabapentin 600 mg Tablets Recalled Due to Metformin Contamination
FDA (Drugs) · 2024-08-14
- ModerateGabapentin tablets recalled due to product mixup with foreign tablet
FDA (Drugs) · 2023-05-17
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22